Beneficial Effects of Spirulina Supplementation in the Management of Cardiovascular Diseases
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
In recent decades, as a result of rising mortality rates due to cardiovascular diseases (CVDs), there has been a growing urgency to find alternative approaches to conventional pharmaceutical treatment to prevent the onset of chronic diseases. Arthrospira platensis, commonly known as Spirulina, is a blue-green cyanobacterium, classified as a “superfood”, used worldwide as a nutraceutical food supplement due to its remarkable nutritional value, lack of toxicity, and therapeutic effects. Several scientific studies have evaluated the cardioprotective role of Spirulina. This article presents a comprehensive review of the therapeutic benefits of Spirulina in improving cardio- and cerebrovascular health. It focuses on the latest experimental and clinical findings to evaluate its antihypertensive, antidiabetic, and antihyperlipidemic properties. The objective is to highlight its potential in preventing and managing risk factors associated with cardiovascular disease (CVD).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132 · cited 1×
“The International Society of Hypertension Global Hypertension Practice Guidelines indicate that hypertension can be diagnosed as a systolic blood pressure (SBP) ≥ 140 mmHg and/or diastolic blood pressure (DBP) ≥ 90 mmHg [35].”
BackgroundFerence, B. A., Ginsberg, H. N., Graham, I., Ray, K. K., Packard, C. J., Bruckert, E., Hegele, R. A., Krauss, R. M., Raal, F. J., Schunkert, H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx144 · Cited by 3,962 · cited 1×
“In addition, the combination of other risk factors such as smoking and a sedentary lifestyle represents a significant correlation with atherosclerotic cardiovascular disorders [81].”
BackgroundHu, F. B. (2011) · Diabetes Care · doi:10.2337/dc11-0442 · Cited by 1,954 · cited 1×
“…diagnosed cases of diabetes and is considered a risk factor for the development of CVDs, including myocardial infarction, peripheral vascular disease (PVD), heart failure, stroke, retinopathy, and neuropathy, as a result of microvascular and macrovascular complications due to hyperglycemia [58].”
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.002 · Cited by 1,751
Thompson, P. D., Clarkson, P., & Karas, R. H. (2003) · JAMA · doi:10.1001/jama.289.13.1681 · Cited by 1,463 · cited 1×
“However, statin treatment is linked to adverse outcomes, including muscle weakness, muscle cramps, persistent myalgias, and elevations in creatine kinase levels [82].”
BackgroundOparil, S., Acelajado, M. C., Bakris, G. L., Berlowitz, D. R., Cífková, R., Dominiczak, A. F., Grassi, G., Jordan, J., Poulter, N. R., Rodgers, A., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.14 · Cited by 1,167
Spirulina Platensis Arthrospira
(1997) · doi:10.1201/9781482272970 · Cited by 704
Hypertension and Cerebrovascular Dysfunction
Iadecola, C., & Davisson, R. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.010 · Cited by 557
Standards of Medical Care in Diabetes—2019 Abridged for Primary Care Providers
American Diabetes Association (2019) · Clinical Diabetes · doi:10.2337/cd18-0105 · Cited by 539
Hypolipidemic, Antioxidant, and Antiinflammatory Activities of Microalgae Spirulina
Deng, R., & Chow, T. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00200.x · Cited by 435
Spirulina for the Food and Functional Food Industries
Lafarga, T., Fernández-Sevilla, J. M., González-López, C., & Acién-Fernández, F. G. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109356 · Cited by 417 · cited 2×
“Specifically, the main proteins present in Spirulina consist of phycocyanin, allophycocyanin, and phycoerythrin [21].”
BackgroundLafarga, T. (2019) · Algal Research · doi:10.1016/j.algal.2019.101566 · Cited by 296
Nagaoka, S., Shimizu, K., Kaneko, H., Shibayama, F., Morikawa, K., Kanamaru, Y., Otsuka, A., Hirahashi, T., & Kato, T. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.10.2425 · Cited by 246
Dietary supplementation with blueberries, spinach, or spirulina reduces ischemic brain damage
Wang, Y., Chang, C.-F., Chou, J., Chen, H.-L., Deng, X., Harvey, B. K., Cadet, J. L., & Bickford, P. C. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.12.014 · Cited by 223 · cited 1×
“…that after ischemia/reperfusion, rats who were pre-treated with approximately 30 g of a Spirulina -enriched diet for four weeks showed reduced cerebral infarction and lower caspase-3 activity ( p < 0.05) compared to the control group indicating a neuroprotective effect of blue-green alga [47].”
BackgroundInfluentialGarrido-Cardenas, J. A., Manzano-Agugliaro, F., Acien-Fernandez, F. G., & Molina-Grima, E. (2018) · Algal Research · doi:10.1016/j.algal.2018.08.005 · Cited by 216
Chemical Characterization of Six Microalgae with Potential Utility for Food Application
Matos, Â. P., Feller, R., Moecke, E. H. S., de Oliveira, J. V., Junior, A. F., Derner, R. B., & Sant'Anna, E. S. (2016) · Journal of the American Oil Chemists Society · doi:10.1007/s11746-016-2849-y · Cited by 196 · cited 1×
“Its low lipid composition is characterized by polyunsaturated essential fatty acids (PUFAs) such as omega-3 eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) [23], omega-6 arachidonic (AA), and γ linolenic acid (GLA) [24].”
BackgroundRole of Spirulina in the Control of Glycemia and Lipidemia in Type 2 Diabetes Mellitus
Parikh, P., Mani, U., & Iyer, U. (2001) · Journal of Medicinal Food · doi:10.1089/10966200152744463 · Cited by 193 · cited 1×
“Another clinical study showed that 2 g/day of Spirulina capsules, taken during lunch and dinner for 2 months, led to a reduction in FBS, PPBS, and HbA1c ( p 0.05) from the baseline to the endpoint [68].”
BackgroundInfluentialChlorophyll production from Spirulina platensis: cultivation with urea addition by fed-batch process
Rangel-Yagui, C. D. O., Danesi, E. D. G., de Carvalho, J. C. M., & Sato, S. (2004) · Bioresource Technology · doi:10.1016/j.biortech.2003.09.002 · Cited by 187
Torres-Duran, P. V., Ferreira-Hermosillo, A., & Juarez-Oropeza, M. A. (2007) · Lipids in Health and Disease · doi:10.1186/1476-511x-6-33 · Cited by 181
Serban, M.-C., Sahebkar, A., Dragan, S., Stoichescu-Hogea, G., Ursoniu, S., Andrica, F., & Banach, M. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2015.09.007 · Cited by 156 · cited 1×
“The effect of Spirulina on plasma lipid levels is independent of the dose administered and has no toxic effects [83].”
BackgroundIWATA, K., INAYAMA, T., & KATO, T. (1990) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.36.165 · Cited by 153
Identification of anti-diabetes peptides from Spirulina platensis
Hu, S., Fan, X., Qi, P., & Zhang, X. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.03.024 · Cited by 150
Rosa, G. M. D., Moraes, L., Cardias, B. B., Souza, M. D. R. A. Z. D., & Costa, J. A. V. (2015) · Bioresource Technology · doi:10.1016/j.biortech.2015.05.020 · Cited by 143
Strasky, Z., Zemankova, L., Nemeckova, I., Rathouska, J., Wong, R. J., Muchova, L., Subhanova, I., Vanikova, J., Vanova, K., Vitek, L., et al. (2013) · Food & Function · doi:10.1039/c3fo60230c · Cited by 87 · cited 1×
“Phycocyanobilin (PCB), its tetrapyrrole chromophore, also showed an antioxidant effect, significantly increasing HMOX1 expression in aortic atherosclerotic plaques of ApoE-deficient mice, thus inducing atheroprotection [104].”
BackgroundMartínez-Sámano, J., Torres-Montes de Oca, A., Luqueño-Bocardo, O. I., Torres-Durán, P. V., & Juárez-Oropeza, M. A. (2018) · doi:10.20944/preprints201811.0283.v1 · Cited by 73 · cited 3×
“In line with these findings, Mart í nez-S á mano and colleagues [41] showed that the administration of 4.5 g/day of Spirulina maxima for 12 weeks in 16 patients with systemic arterial hypertension (SAH), treated with angiotensin-converting enzyme (ACE) inhibitors, resulted in a significant…”
BackgroundMethodResultInfluentialHAN, L.-K., LI, D.-X., XIANG, L., GONG, X.-J., KONDO, Y., SUZUKI, I., & OKUDA, H. (2006) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.126.43 · Cited by 66 · cited 1×
“Furthermore, according to Han et al., C-phycocyanin and glycolipid H-b2 inhibit pancreatic lipase activity in a dose-dependent manner [101].”
Carcea, M., Sorto, M., Batello, C., Narducci, V., Aguzzi, A., Azzini, E., Fantauzzi, P., Finotti, E., Gabrielli, P., Galli, V., et al. (2015) · LWT - Food Science and Technology · doi:10.1016/j.lwt.2014.10.039 · Cited by 45
Suo, Q., Yue, Y., Wang, J., Wu, N., Geng, L., & Zhang, Q. (2022) · Food & Function · doi:10.1039/d2fo01207c · Cited by 39 · cited 1×
“Two other lyophilized peptides derived from Spirulina digestion were orally administered to SHR rats and have been shown to lower blood pressure for up to 8 h after supplementation compared to captopril, suggesting they have a longer-lasting ACE-inhibiting effect than captopril [45].”
MethodGhaem Far, Z., Babajafari, S., Kojuri, J., Mohammadi, S., Nouri, M., Rostamizadeh, P., Rahmani, M. H., Azadian, M., Ashrafi‐Dehkordi, E., Zareifard, A., et al. (2021) · Phytotherapy Research · doi:10.1002/ptr.7254 · Cited by 39
El-Sayed, E.-S., Hikal, M., Abo El- Khair, B., El-Ghobashy, R., & El-Assar, A. (2018) · Arab Universities Journal of Agricultural Sciences · doi:10.21608/ajs.2018.28365 · Cited by 26
Cited by
Spínola, M. P., Mendes, A. R., & Prates, J. A. M. (2024) · Foods · doi:10.3390/foods13223656 · Cited by 146
Podgórska-Kryszczuk, I. (2024) · Molecules · doi:10.3390/molecules29225387 · Cited by 88
Hussein, A. M. S., Mostafa, S., Ata, S. M., Hegazy, N. A., Abu-Reidah, I. M., & Zaky, A. A. (2025) · Processes · doi:10.3390/pr13030625 · Cited by 19
Kamel, M., Aleya, S., Louzon, M., & Aleya, L. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04113-0 · Cited by 2
Metadata
- Authors
- Prete, V., Abate, A. C., Di Pietro, P., De Lucia, M., Vecchione, C., & Carrizzo, A.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2024-02-25
- Volume
- 16
- Issue
- 5
- Pages
- 642
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W4392166637
- Cited by
- 48
- References
- 31
- FWCI
- 14.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.